KYUYONG CHO

Assistant Professor

Hokkaido University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kyuyong Cho is an Assistant Professor at Hokkaido University in Japan. His research focuses on diabetes management, including studies on the efficacy of medications like tirzepatide and semaglutide, as well as the impacts of diet on blood glucose levels. Recent publications also explore the relationships between lipid management, insulin resistance, and glucose variability in patients with type 2 diabetes.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Aika Miya

Project Assistant Professor

Hokkaido University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

KYUYONG CHO

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study

Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study

Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study

Impact of low-starch high-fiber pasta on postprandial blood glucose

Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study

Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment

Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia

Collaborators (1)

Aika Miya

Make your next move.